1
|
Zahran MM, Elshreif AM, Abou-Eladab E, Altawel AA. A Cross-sectional Study of Iron Deficiency Anemia and Hemoglobinopathy Carriers among School Children in Two Different Cities in KSA. Open Access Maced J Med Sci 2022. [DOI: 10.3889/oamjms.2022.9311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Aim: Iron deficiency anemia (IDA) is the most common cause of anemia in the Kingdom of Saudi Arabia. Thalassemia and sickle cell disease (SCD) are major concerns in several nations, including KSA. This study sought to investigate the prevalence of IDA, sickle cell trait (SCT), and B thalassemia trait (BTT) among school children in Al-Khobar and Makkah, Saudi Arabia.
Methods: A multistage random sample of 570 school children aged 12–18 years from both cities were educated about these illnesses and tested for CBC, serum iron, TIBC, reticulocytosis, and sickling. In some circumstances, hemoglobin electrophoresis and HPLC were used.
Results: Overall, 13% of people had IDA, 3.2 percent had SCT, and 2.5 percent had BTT. The hematological parameters of students with IDA and BTT differed significantly from those of normal students in each city, but not between normal students and those with SCT. There were no significant differences between the sexes for all blood parameters except iron and TIBC.
Conclusion: Strengthening public health education, dietary initiatives, and school-based hemoglobinopathy carrier screening is proposed to help detect anemia early.
Collapse
|
2
|
Elkoumi MA, Allah MA, Mohamed FY, Boraey NF, Abdellatif SH, Shehab MM, Sherif AH, Akeel NE, Saleh RM, Elshreif AM, Abdelrahman HM, Soliman AA, Emam AA, Youssef MA, Fahmy DS, Sallam MM, Nawara AM, Elgohary EA, Ismael A, El-Kaffas SM, Sobeih AA, Ibrahim LM, Ibrahim MA, Abdou AM, Yousry SM, Osman SF, El-Deeb FM, Elhewala AA, Hafez SF, Waked NM, Elbasyouni HA, Fouad RA, Zeidan NM, Nashat M, Farghaly MA. Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study. Lupus 2020; 29:767-775. [PMID: 32380889 DOI: 10.1177/0961203320922305] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Recently, the interleukin-17A (IL-17A) gene has emerged as a potential candidate gene for autoimmune disorders, including systemic lupus erythematosus (SLE). OBJECTIVES This study aimed to investigate whether IL-17A polymorphisms at rs2275913 G/A, rs8193036 C/T and rs3748067 C/T could be susceptibility markers for juvenile-onset SLE (JSLE) and lupus nephritis (LN) in Egyptian children and adolescents. METHODS In this multi-centre study, we genotyped 320 patients diagnosed with JSLE and 320 matched control children for three IL-17A polymorphisms at rs2275913 G/A, rs8193036 C/T and rs3748067 C/T using TaqMan probe-based real-time polymerase chain reaction. Meanwhile, IL-17A serum levels were assessed using ELISA. RESULTS The IL-17 rs2275913 A/A genotype and A allele were more represented in JSLE patients compared to the control group (21% vs. 7%, odds ratio (OR) = 3.8, 95% confidence interval (CI) 1.78-5.5, p = 0.001, pBonf = 0.003 for the A/A genotype; 37% vs. 29%, OR = 1.4, 95% CI 1.11-1.8, p = 0.003, pBonf = 0.009 for the A allele. No significant difference was found for IL-17 rs8193036 and rs3748067 single nucleotide polymorphisms (SNPs) in genotype distribution or allele frequencies (p>0.05). Patients carrying the IL-17 rs2275913 A/A genotype and A allele were more likely to develop LN (OR = 5.64, 95% CI 2.39-13.77, pBonf = 0.001 for the A/A genotype; OR = 2.73, 95% CI 1.84-4.07, pBonf = 0.02 for the A allele). CONCLUSION The IL-17 rs2275913 A allele and A/A genotype were associated with high IL-17 serum levels and may contribute to susceptibility to JSLE and the development of LN in Egyptian children and adolescents. However, no significant association was evident between the studied IL-17A SNPs and other clinical phenotypes, disease activity scores or laboratory profile of JSLE.
Collapse
Affiliation(s)
- Mohamed A Elkoumi
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Mayy An Allah
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Faisal Y Mohamed
- Department of Paediatrics, Faculty of Medicine, Ain-Shams University, Egypt
| | - Naglaa F Boraey
- Department of Paediatrics, Faculty of Medicine, Sohag University, Egypt
| | | | - Mohamed Mm Shehab
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Ahmed H Sherif
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Nagwa E Akeel
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Rabab M Saleh
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Anas M Elshreif
- Department of Paediatrics, Faculty of Medicine, Al Azhar University, Egypt
| | - Hind M Abdelrahman
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Attia A Soliman
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Ahmed A Emam
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Manal Aa Youssef
- Department of Rheumatology, Faculty of Medicine, Zagazig University, Egypt
| | - Dalia S Fahmy
- Department of Rheumatology, Faculty of Medicine, Zagazig University, Egypt
| | - Mohammad M Sallam
- Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - Abdalla M Nawara
- Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - Elsayed A Elgohary
- Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - Ali Ismael
- Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | | | - Alaa A Sobeih
- Department of Paediatrics, Faculty of Medicine, Cairo University, Egypt
| | - Lamya M Ibrahim
- Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Egypt
| | - Mohamed Am Ibrahim
- Department of Clinical Pathology, Faculty of Medicine, Sohag University, Egypt
| | - Adel M Abdou
- Department of Clinical Pathology, Faculty of Medicine, Al Azhar University, Egypt
| | - Sherif M Yousry
- Department of Clinical pathology, Faculty of Medicine, Cairo University, Egypt
| | - Sherif F Osman
- Department of Radiology, Texas Tech University Health Sciences Center El Paso, USA
| | - Fatma M El-Deeb
- Department of Dermatology, Faculty of Medicine, Zagazig University, Egypt
| | - Ahmed A Elhewala
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Sahbaa Fm Hafez
- Department of Paediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - Nevin M Waked
- Department of Paediatrics, Faculty of Medicine, October 6 University, Egypt
| | - Hany Aa Elbasyouni
- Department of Internal Medicine, Faculty of Medicine, Menoufia University, Egypt
| | - Rania A Fouad
- Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Egypt
| | - Nancy Ms Zeidan
- Department of Paediatrics, Faculty of Medicine, Cairo University, Egypt
| | - Mohamed Nashat
- Department of Paediatrics, Faculty of Medicine, Aswan University, Egypt
| | | |
Collapse
|
3
|
Elkoumi MA, Abdellatif SH, Mohamed FY, Sherif AH, Elashkar SSA, Saleh RM, Boraey NF, Abdelaal NM, Akeel NE, Elhewala AA, Mosbah AA, Zakaria MT, Soliman MM, Salah A, Sedky YM, Sobieh AA, Mashali MH, Waked NM, Elshreif AM, Hafez SF, Hashem MIA, Shehab MM, Soliman AA, Emam AA, Ahmed AAA, Fahim MS, Elshehawy NA, Abdel-Aziz MM, Abdou AM, El-Shehawy AA, Youssef MAA, Fahmy DS, Malek MM, Osman SF, Ibrahim MAM, Alanwar MI, Zeidan NMS. Ficolin-1 gene (FCN1) -144 C/A polymorphism is associated with adverse outcome of severe pneumonia in the under-five Egyptian children: A multicenter study. Pediatr Pulmonol 2020; 55:1175-1183. [PMID: 32142211 DOI: 10.1002/ppul.24719] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/24/2019] [Accepted: 02/22/2020] [Indexed: 12/18/2022]
Abstract
BACKGROUND Pneumonia is the foremost cause of child death worldwide. M-ficolin is encoded by the FCN1 gene and represents a novel link between innate and adaptive immunity. OBJECTIVES To investigate the FCN1 -144 C/A (rs10117466) polymorphism as a potential marker for pneumonia severity and adverse outcome namely complications or mortality in the under-five Egyptian children. METHODS This was a prospective multicenter study that included 620 children hospitalized with World Health Organization-defined severe pneumonia and 620 matched healthy control children. Polymorphism rs10117466 of the FCN1 gene promoter was analyzed by PCR-SSP, while serum M-ficolin levels were assessed by ELISA. RESULTS The FCN1 A/A genotype and A allele at the -144 position were more frequently observed in patients compared to the control children (43.4% vs 27.6%; odds ratio [OR]: 1.62; [95% confidence interval {CI}: 1.18-2.2]; for the A/A genotype) and (60.8% vs 52.5%; OR: 1.4; [95% CI: 1.19-1.65]; for the A allele); P < .01. The FCN1 -144 A/A homozygous patients had significantly higher serum M-ficolin concentrations (mean: 1844 ± 396 ng/mL) compared with those carrying the C/C or C/A genotype (mean: 857 ± 278 and 1073 ± 323 ng/mL, respectively; P = .002). FCN1 -144 A/A genotype was an independent risk factor for adverse outcomes in children with severe pneumonia (adjusted OR = 4.85, [95% CI: 2.96-10.25]; P = .01). CONCLUSION The FCN1 A/A genotype at the -144 position was associated with high M-ficolin serum levels and possibly contributes to enhanced inflammatory response resulting in the adverse outcome of pneumonia in the under-five Egyptian children.
Collapse
Affiliation(s)
- Mohamed A Elkoumi
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Sawsan H Abdellatif
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Faisal Y Mohamed
- Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
| | - Ahmed H Sherif
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Shaimaa S A Elashkar
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Rabab M Saleh
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Naglaa F Boraey
- Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag, Egypt
| | - NourEldin M Abdelaal
- Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
| | - Nagwa E Akeel
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Ahmed A Elhewala
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Amira A Mosbah
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Mervat T Zakaria
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Mohammed M Soliman
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Ahmed Salah
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Yasser M Sedky
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Alaa A Sobieh
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Mohamed H Mashali
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| | - Nevin M Waked
- Department of Pediatrics, Faculty of Medicine, October 6 University, Cairo, Egypt
| | - Anas M Elshreif
- Department of Pediatrics, Faculty of Medicine, Al Azhar University, Cairo, Egypt
| | - Sahbaa F Hafez
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Mustafa I A Hashem
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Mohamed M Shehab
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Attia A Soliman
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Ahmed A Emam
- Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | | | - Mohamed S Fahim
- Department of Anathesia, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
| | - Naglaa A Elshehawy
- Department of Anathesia, Faculty of Medicine, Al Azhar University, Cairo, Egypt
| | - Marwa M Abdel-Aziz
- Department of Anathesia, Faculty of Medicine, Al Azhar University, Cairo, Egypt
| | - Adel M Abdou
- Department of Clinical pathology, Faculty of Medicine, Al Azhar University, Cairo, Egypt
| | - Ahmed A El-Shehawy
- Department of Physical Therapy for Cardiovascular/Respiratory Disorder, Faculty of Physical Therapy, Cairo University, Giza, Egypt
| | - Manal A A Youssef
- Department of Rheumatology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Dalia S Fahmy
- Department of Rheumatology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Mai M Malek
- Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Sherif F Osman
- Department of Radiology, Texas Tech University Health Sciences Center El Paso, El Paso, Texas
| | - Mohamed A M Ibrahim
- Department of Clinical pathology, Faculty of Medicine, Sohag University, Egypt
| | - Mohamed I Alanwar
- Department of Cardiothoracic surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | - Nancy M S Zeidan
- Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt
| |
Collapse
|
4
|
Elkoumi MA, Emam AA, Allah MAN, Sherif AH, Abdelaal NM, Mosabah A, Zakaria MT, Soliman MM, Salah A, Sedky YM, Mashali MH, Elashkar SSA, Hafez SFM, Hashem MIA, Elshreif AM, Youssef M, Fahmy DS, Sallam MM, Nawara AM, Elgohary EA, Ahmed AA, Fahim MS, Fawzi MM, Abdou AM, Morsi SS, Abo-Alella DA, Malek MM, Anany HG, Sobeih AA, Elbasyouni HAA, El-Deeb FM. Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study. Lupus 2019; 28:995-1002. [PMID: 31184250 DOI: 10.1177/0961203319856089] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND Pediatric-onset SLE (pSLE) is a multisystem autoimmune disease. Recently, the ficolin-2 (FCN2) gene has emerged as a potential candidate gene for susceptibility to SLE. OBJECTIVES The objective of this study was to evaluate the association of the FCN2 gene polymorphisms at positions -986 (G/A), -602 (G/A), -4 (A/G) and SNP C/T (rs3124954) located in intron 1, with susceptibility to pSLE in Egyptian children and adolescents. METHODS This was a multicenter study of 280 patients diagnosed with pSLE, and 280 well-matched healthy controls. The FCN2 promoter polymorphisms at -986 G/A (rs3124952), -602 G/A (rs3124953), -4 A/G (rs17514136) and SNP C/T (rs3124954) located in intron 1 were genotyped by polymerase chain reaction, while serum ficolin-2 levels were assessed using enzyme-linked immunosorbent assay. RESULTS The frequencies of the FCN2 GG genotype and G allele at -986 and -602 positions were significantly more represented in patients with pSLE than in controls (p < 0.001). Conversely, the FCN2 AA genotype and A allele at position -4 were more common in patients than in controls (p < 0.001). Moreover, patients carrying the FCN2 GG genotype in -986 position were more likely to develop lupus nephritis (odds ratio: 2.6 (95% confidence interval: 1.4-4.78); p = 0.006). The FCN2 AA genotype at position -4 was also identified as a possible risk factor for lupus nephritis (odds ratio: 3.12 (95% confidence interval: 1.25-7.84); p = 0.024). CONCLUSION The FCN2 promoter polymorphisms may contribute to susceptibility to pSLE in Egyptian children and adolescents. Moreover, the FCN2 GG genotype at position -986 and AA genotype at position -4 were associated with low serum ficolin-2 levels and may constitute risk factors for lupus nephritis in pSLE.
Collapse
Affiliation(s)
- M A Elkoumi
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - A A Emam
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - M A N Allah
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | | | - N M Abdelaal
- 2 Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Egypt
| | - Aaa Mosabah
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - M T Zakaria
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - M M Soliman
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - A Salah
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - Y M Sedky
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - M H Mashali
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - S S A Elashkar
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - S F M Hafez
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - M I A Hashem
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - A M Elshreif
- 4 Department of Pediatrics, Al Azhar Faculty of Medicine, Cairo, Egypt
| | - Maa Youssef
- 5 Department of Rheumatology, Faculty of Medicine, Zagazig University, Egypt
| | - D S Fahmy
- 5 Department of Rheumatology, Faculty of Medicine, Zagazig University, Egypt
| | - M M Sallam
- 6 Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - A M Nawara
- 6 Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - E A Elgohary
- 6 Department of Internal Medicine, Faculty of Medicine, Zagazig University, Egypt
| | - A A Ahmed
- 7 Department of Anesthesia, Faculty of Medicine, Zagazig University, Egypt
| | - M S Fahim
- 8 Department of Anesthesia, Faculty of Medicine, Ain-Shams University, Egypt
| | - M M Fawzi
- 9 Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Egypt
| | - A M Abdou
- 10 Department of Clinical Pathology, Al Azhar Faculty of Medicine, Cairo, Egypt
| | - S S Morsi
- 11 Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Egypt
| | - D A Abo-Alella
- 11 Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Egypt
| | - M M Malek
- 11 Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Egypt
| | - H G Anany
- 1 Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt
| | - A A Sobeih
- 3 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
| | - H A A Elbasyouni
- 12 Department of Internal Medicine, Faculty of Medicine, Menoufia University, Egypt
| | - F M El-Deeb
- 13 Department of Dermatology, Faculty of Medicine, Zagazig University, Egypt
| |
Collapse
|